|
|
|
| Effect analysis of Alteplase thrombolysis in the treatment of ST-segment elevation acute myocardial infarction |
| ZHAO Wen-juan |
| Department of Cardiovascular Medicine,Central Hospital of Hengyang City in Hunan Province,Hengyang421000,China |
|
|
|
|
Abstract Objective To investigate effect of Alteplase thrombolysis in the treatment of ST-segment elevation acute myocardial infarction.Methods 152 patients with ST-segment elevation acute myocardial infarction treated in our hospital from October 2012 to October 2015 were selected and divided into control group and observation group by random number table method,76 cases in each group.Patients in the control group were treated with Urokinase,while patients in the observation group treated with Alteplase.Electrocardiogram was detected before and after treatment.Cardiovascular reperfusion was analyzed at different time points.Clinical efficacy and adverse reactions were compared between two groups.Results Compared with before treatment,Q wave time,Q wave/R wave,ST segment deviation after treatment was decreased in two groups(P＜0.01);Q wave time[(0.042±0.009)d],Q wave/R wave(0.31±0.06),ST segment deviation[(3.20± 0.57)mV]in the observation group was lower than that in the control group[(0.051±0.010)d,0.36±0.05,(4.35±0.61)mV] (P＜0.01).Compared at same time points in the group,cardiovascular reperfusion rate of patients with onset time≤6 h was higher than that of patients with onset time＞6 h(P＜0.05);compared at same time points between two groups,cardiovascular reperfusion rate in the observation group was higher than that in the control group(P＜0.05).Total effective rate in the observation group was higher than that in the control group(97.4%vs.82.9%)(P＜0.01).Incidence of adverse reactions in the observation group was lower than that in the control group(2.6%vs.13.2%),and the difference was statistically significant(P＜0.05).Conclusion Alteplase thrombolysis has significant effect in the treatment of ST-segment elevation acute myocardial infarction,which has high safety,which is worthy of clinical application.
|
|
|
|
|
|
| [1] |
武国东，刘永生，林光柱，等.血栓抽吸术合并介入治疗急性ST段抬高型心肌梗死的Meta分析[J].中国老年学杂志，2014，34（17）：4805-4807.
|
| [2] |
刘卫其，张励庭，黄炫生，等.急性ST段抬高型心肌梗死的急诊介入治疗与择期介入治疗预后对比[J].中国动脉硬化杂志，2011，19（9）：781-784.
|
| [3] |
张纪梅.尿激酶溶栓治疗发病2h内急性ST段抬高型心肌梗死的疗效[J].中国老年学杂志，2013，33（1）：170-171. [4]郭儒雅，武阳丰，赵威，等.急性ST段抬高型心肌梗死患者溶栓治疗时间对住院期间主要不良心脏事件发生率的影响[J].中华心血管病杂志，2016，44（2）：128-132.
|
| [5] |
中华医学会心血管分会，中华心血管临床杂志编辑委员会，中国循环杂志编委会.急性心肌梗死诊断与治疗指南[J].中华心血管病杂志，2001，29（12）：710-725.
|
| [6] |
李杰华，金红，杨海侠.阿替普酶与尿激酶分别联合依诺肝素钠治疗急性ST段抬高型心肌梗死的临床观察[J].中国药房，2016，27（20）：2830-2833.
|
| [7] |
张妮，向定成，张金霞，等.吸烟对不同性别、年龄人群急性ST段抬高型心肌梗死发病风险的相关性研究[J].中国循环杂志，2016，31（9）：858-861.
|
| [8] |
韦冬梅.冠状动脉造影正常的急性ST段抬高心肌梗死临床分析[J].中西医结合心脑血管病杂志，2015，13（12）：1429-1430.
|
| [9] |
张步春，周志文，侯磊，等.静脉溶栓联合早期经皮冠状动脉介入治疗急性ST段抬高型心肌梗死的荟萃分析[J].中华医学杂志，2011，91（28）：1961-1965.
|
| [10] |
吕云，高彦.瑞替普酶与阿替普酶在急性ST段抬高型心肌梗死溶栓治疗中的临床对比分析[J].现代中西医结合杂志，2014，23（11）：1197-1199.
|
| [11] |
王金凤，魏颖，王芳，等.替罗非班在急性心肌梗死溶栓治疗中的作用[J].中国临床医学，2015，22（4）：491-493.
|
| [12] |
吴伟生.尿激酶联合左旋精氨酸治疗急性ST段抬高型心肌梗死的疗效观察[J].中外医疗，2012，31（1）：81-83.
|
| [13] |
赵蓓，刘利峰，刘瑛琪，等.冠状动脉内小剂量尿激酶溶栓联合支架植入对急性ST段抬高型心肌梗死患者心肌灌注及短期预后的影响[J].解放军医学杂志，2015，40（8）：661-665.
|
| [14] |
陈国琴，史丹君.阿替普酶溶栓治疗早期急性ST段抬高型心肌梗死的观察[J].中国血液流变学杂志，2014，24（1）：177-178.
|
| [15] |
帅锋利，宋剑琼，苏代泉，等.阿替普酶溶栓治疗急性ST段抬高型心肌梗死30例临床体会[J].当代医学，2011，17（12）：72-73.
|
| [16] |
陈泽江，黄修献.阿替普酶与尿激酶溶栓治疗急性心肌梗死疗效观察[J].现代中西医结合杂志，2016，25（10）：1087-1089.
|
| [17] |
任学良，张吉廷.阿替普酶溶栓治疗ST段抬高型心肌梗死的临床评价[J].西南国防医药，2014，24（8）：843-845.
|
|
|
|
